Natriuretic Peptide Type A (NPPA) (AA 1-28) peptide
Description
Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate cyclase, has been found to protect against reoxygenation-induced hypercontracture in isolated cardiomyocytes by increasing cyclic guanosine monophosphate synthesis, ANP also contributes to stimulation of lipolysis during repeated bouts of exercise and in the control of lipolysis during exercise.